NovoSeven HI 5mg syringe for intravenous injection

NovoSeven HI 5mg syringe for intravenous injection (YJ code: 6343434D8022, 5mg 5mL 1 bottle (with dissolving solution)), manufactured by Novo Nordisk Pharma, contains Eptacog alpha (activated) (genetical recombination). This recombinant factor VIIa is used for the treatment and prevention of bleeding episodes in patients with congenital hemophilia with inhibitors, acquired hemophilia, congenital FVII deficiency, and Glanzmann’s thrombasthenia.